Close

Intercept Pharmaceuticals (ICPT) PT Lowered to $22 at Needham & Company on "Concerns Around Overall Benefit/Safety Profile" of OCA Jul 8, 2022 06:17AM
Intercept Pharmaceuticals (ICPT) PT Lowered to $25 at Needham & Company, Analyst Does Not Anticipate Phase 3 REVERSE Trial to Have a Positive Outcome Mar 2, 2022 03:57PM
Intercept Pharmaceuticals (ICPT) PT Lowered to $25 at Needham & Company Mar 2, 2022 03:57PM
Intercept Pharmaceuticals (ICPT) PT Lowered to $30 at Needham & Company Jul 29, 2021 01:24PM
Intercept Pharmaceuticals (ICPT) PT Lowered to $34 at Needham & Company; 'Low Visibility on Regulatory Path Forward in NASH' Mar 2, 2021 08:05AM
View Older Stories

Jun 30, 2020 07:13AM Intercept Pharmaceuticals (ICPT) PT Lowered to $100 at Needham & Company
May 10, 2019 08:31AM Intercept Pharma (ICPT) Prices Offerings of Common Stock and Convertible Senior Notes due 2026
May 10, 2019 08:30AM Intercept Pharmaceuticals Announces Pricing of Offerings of Common Stock and Convertible Senior Notes due 2026
Feb 19, 2019 10:42AM Intercept Pharmaceuticals (ICPT) Bullish View Reiterated at Needham & Company on Positive Positive Phase 3 REGENERATE NASH Trial
Jan 24, 2019 09:20AM Pre-Open Stock Movers 1/24: (AZPN) (XLNX) (LRCX) Higher; (BGG) (MKC) (UMPQ) Lower (more...)
Jan 24, 2019 06:50AM Needham & Company Upgrades Intercept Pharmaceuticals (ICPT) to Buy
Aug 6, 2018 09:27AM Pre-Open Movers 08/06: (SEAS) (VTL) (CTWS) Higher; (OVID) (BID) (PX) Lower (more...)
Mar 26, 2018 04:30PM Intercept to Present at Upcoming Conference
Sep 25, 2017 12:25PM Intercept Pharma (ICPT) Impacts On Sales In PBC Should be Minimal - Needham
Mar 30, 2017 04:05PM Intercept to Present at Upcoming Conference
Jan 20, 2017 06:00AM Needham & Company Downgrades Intercept Pharmaceuticals (ICPT) to Hold
Nov 16, 2016 06:38AM Intercept Pharma (ICPT): AASLD Meeting Takeaway - Needham
Jun 24, 2016 11:13AM Needham & Company Weighs in on Brexit Biotech Impact (ACAD) (GILD0 (ICPT) (SGEN)
May 31, 2016 12:09PM Streetinsider.com's Hot Lunchtime Reads 5/31: (AAPL) (MON) (VRX) (ICPT)
May 31, 2016 11:25AM Needham & Company Positive on Intercept Pharma (ICPT); Expects Initial Ocaliva Uptake to be 'Strong'
Apr 8, 2016 06:53AM Needham & Company Reiterates Buy on Intercept Pharma (ICPT) Following Positive FDA Panel Vote on Obeticholic Acid
Dec 2, 2015 07:11AM Intercept Pharmaceuticals (ICPT) Bullish View Reiterated at Needham & Company Following Analyst Meeting
Nov 9, 2015 02:21PM Needham & Company Reiterates Buy on Intercept (ICPT) Following Q3 Update
Oct 28, 2015 11:17AM Needham & Company Reiterates Bullish View on Intercept (ICPT) Despite Narrow-Miss in OCA Phase 2 Japanese NASH Trial
May 11, 2015 12:47PM Intercept's (ICPT) Rolling NDA, MAA Submissions for OCA Appear on Track; Needham & Company Affirms at 'Buy'
Mar 23, 2015 06:46AM Intercept (ICPT) Bullish Stance Reiterated at Needham & Company Amid AASLD Industry Colloquium Review
Feb 10, 2015 04:05PM Intercept Pharmaceuticals Announces Completion of Public Offering and Exercise of Option to Purchase Additional Shares
Feb 5, 2015 06:41AM Intercept Pharma (ICPT) 1M Stock Offering Prices at $176/Share
Feb 4, 2015 07:34PM Intercept Pharmaceuticals Announces Pricing of Public Offering
Nov 11, 2014 08:40AM Intercept Pharmaceuticals (ICPT) Bullish Stance Reiterated at Needham & Company Following AASLD Meeting
Nov 7, 2014 09:32AM Pre-Open Stock Movers 11/07: (MITK) (RMTI) (SHLD) Higher; (SLXP) (ICPT) (GUID) Lower (more...)
Jul 1, 2014 10:44AM Notable Analyst Rating Changes 07/01: (NFLX) (FOLD) (NBR) Upgraded; (GS) (MNKD) (URBN) Downgraded
May 15, 2014 10:28AM Notable Analyst Rating Changes 05/15: (PLUG) (PTX) (TWTR) Upgraded; (BMY) (HII) (CXP) Downgraded
May 8, 2014 07:18AM Intercept Pharmaceuticals (ICPT) Bullish Stance Reiterated at Needham & Company Despite OCA NDA/MAA Push Back
Apr 14, 2014 06:58AM Intercept Pharmaceuticals (ICPT) Bullish Stance Reiterated at Needham & Company
Apr 4, 2014 06:29AM Intercept Pharma (ICPT) Prices 1M Common Offering at $320/Share
Apr 3, 2014 08:41PM Intercept Pharmaceuticals Announces Pricing of Public Offering
Apr 1, 2014 05:38PM Intercept Pharma (ICPT) to Offer 1M Shares
Apr 1, 2014 05:36PM Intercept Pharmaceuticals Announces Proposed Public Offering of Common Stock
Mar 17, 2014 02:08PM Intercept (ICPT) Target Lifted at Needham & Company on Positive Phase 3 Results for OCA in PBC
Jan 10, 2014 07:42AM Intercept Pharmaceuticals (ICPT) Target Lifted to $320 at Needham & Company
Jan 9, 2014 09:39AM Pre-Open Stock Movers 1/9: (ICPT) (CRDC) (F) Higher; (YRCW) (FDO) (PIR) Lower (more...)
Jun 19, 2013 06:30AM Intercept Pharma (ICPT) Prices 1.73M Common Offering at $33.01/Share
Jan 4, 2013 08:48AM Needham & Company Lifts PT on Intercept Pharmaceuticals (IPCT) with OCA Phase 3 POISE Trial Ahead of Schedule
Nov 12, 2012 10:31AM Notable Analyst Rating Changes 11/12: (SQNM) (DIS) (KLAC) Upgraded; (GRMN) (JCP) (SD) Downgraded
Nov 5, 2012 12:10PM BMO Capital Starts Intercept Pharmaceuticals (ICPT) at Outperform
Nov 5, 2012 10:48AM Needham & Company Starts Intercept Pharmaceuticals (ICPT) at Buy
Oct 11, 2012 11:39AM Intercept Pharmaceuticals (ICPT) IPO Trades 26% Higher
Sep 4, 2012 03:38PM Intercept Pharmaceuticals (ICPT) Files $75M IPO
View Older Stories